![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, May 19, 2024 10:22:25 PM
![Bullish](/static/images/ih2-bull.png)
Recent TVGN News
- Tevogen Bio Files Registration Statement for Previously Disclosed Securities; Does Not Relate to Any Previously Undisclosed New Issuances of Dilutive Securities • GlobeNewswire Inc. • 06/26/2024 04:46:13 PM
- Tevogen Bio Announces Publication of Positive Phase I Clinical Trial Results for TVGN 489 in Blood Advances • GlobeNewswire Inc. • 06/25/2024 12:05:00 PM
- Tevogen.AI Head Discusses Company’s Bold Strategy to Shape the Future of T Cell Therapies at Longwood Spring MIT Conference • GlobeNewswire Inc. • 06/18/2024 07:17:05 PM
- Tevogen Bio Set to Join Russell 3000® Index • GlobeNewswire Inc. • 06/12/2024 07:45:00 PM
- Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts • GlobeNewswire Inc. • 06/11/2024 07:30:00 PM
- CORRECTION – Tevogen Bio Expresses Gratitude to Patients, First Responders, Elected Officials, and Members of the United States Congress for Attending Its Inaugural Post-Public Listing Social Engagement Event • GlobeNewswire Inc. • 06/07/2024 07:32:04 PM
- Tevogen Bio Expresses Gratitude to Patients, First Responders, Elected Officials, and Members of the United States Congress for Attending Its Inaugural Post-Listing Social Engagement Event • GlobeNewswire Inc. • 06/06/2024 10:14:31 PM
- Tevogen Bio Confirms Ongoing Efficacy of TVGN 489, Its Investigational Allogeneic Off-the-Shelf Immunotherapy, Against Dominant FLiRT Strains of SARS-CoV-2 • GlobeNewswire Inc. • 06/06/2024 07:52:26 PM
- Tevogen Bio Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/29/2024 12:00:00 PM
- Tevogen Bio Appoints Former Police Chief & FBI National Academy Graduate, William Keane, as Vice President of Strategic Initiatives • GlobeNewswire Inc. • 05/16/2024 06:00:00 PM
- Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives • GlobeNewswire Inc. • 05/10/2024 09:40:49 PM
- Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational Objectives • GlobeNewswire Inc. • 05/01/2024 12:05:00 PM
- Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments • GlobeNewswire Inc. • 04/26/2024 01:23:59 PM
- Tevogen Bio’s Chief Scientific Officer Speaks on the Harnessing of Cytotoxic T Lymphocytes (CTLs) to Target Cancers • GlobeNewswire Inc. • 04/11/2024 12:05:00 PM
- Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development • GlobeNewswire Inc. • 04/03/2024 12:05:00 PM
- Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price • GlobeNewswire Inc. • 03/28/2024 12:05:00 PM
- Tevogen Bio Reports Its Investigational SARS-CoV-2 Specific T Cell Therapy, TVGN-489, Retains Activity Against the Dominant JN.1 Variant • Business Wire • 03/20/2024 11:00:00 AM
- Tevogen Bio Holdings Congratulates its Board Member and Esteemed Global Safety Management Expert, Victor Sordillo, on His appointment as Managing Director of Risk Advisory Services at Verita • Business Wire • 03/05/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 03/04/2024 09:24:14 PM
- Mittul Mehta, Head of Tevogen's Artificial Intelligence Initiative Tevogen.ai, Emphasizes Importance of Proactive Talent Development for Biopharmaceutical Sector to Allow Rapid Adoption of AI • Business Wire • 02/27/2024 09:39:00 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 02/23/2024 01:13:20 AM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 02/23/2024 01:09:42 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:30:46 PM
- Cell Therapy Company Tevogen Bio Holdings Inc. Prepares to Launch Crucial Genetic Predisposition Study in Preparation to Investigate the Potential of TVGN 489 to Address Critical Unmet Need for Long COVID Treatment • Business Wire • 02/21/2024 12:00:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/20/2024 01:57:33 PM
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM